Antiparasitic Agents < Antiparkinson Agents < Antipsychotic Agents

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 358.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000076 (2016)	Matthieu F. Bastide [France] ; Simone Bido [France] ; Nathalie Duteil [France] ; Erwan Bézard [France]	Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia.
000081 (2016)	Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France]	Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
000094 (2016)	Leslie Mazuel [France] ; Carine Chassain [France] ; Betty Jean [France] ; Bruno Pereira [France] ; Aurélie Cladière [France] ; Claudine Speziale [France] ; Franck Durif [France]	Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson Disease.
000139 (2016)	Jean-Marc Taymans [France] ; Elisa Greggio [Italie]	LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
000181 (2016)	Clément François [États-Unis] ; Robert A. Hauser [États-Unis] ; Samuel Aballéa [France] ; Julie Dorey [États-Unis] ; Elizaveta Kharitonova [France] ; L Arthur Hewitt [États-Unis]	Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
000207 (2016)	Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]	Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000221 (2016)	N. Simon [France] ; F. Viallet [France] ; A. Boulamery [France] ; A. Eusebio [France] ; D. Gayraud [France] ; J-P Azulay [France]	A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.
000222 (2016)	Michael Feyder [Suède] ; Erik Södersten [Danemark] ; Emanuela Santini [Suède] ; Vincent Vialou [France] ; Quincey Laplant [États-Unis] ; Emily L. Watts [États-Unis] ; Giada Spigolon [Suède] ; Klaus Hansen [Danemark] ; Jocelyne Caboche [France] ; Eric J. Nestler [États-Unis] ; Gilberto Fisone [Suède]	A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression.
000237 (2015)	Pierre Grandgenevre [France] ; Frédérique Warembourg [France] ; Nicolas Carrière [France] ; Alexandra Vaillant [France] ; Luc Defebvre [France] ; Guillaume Vaiva [France]	[Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].
000242 (2015)	Michel Engeln [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] ; Pierre-Olivier Fernagut [France]	Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia.
000263 (2015)	Marianne Amalric [France]	Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
000268 (2015)	Mathieu Anheim [France] ; Patricia Dowsey-Limousin [France] ; Paul Krack [France] ; Stéphan Chabardès [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]	Subthalamic stimulation or subthalamic lesion for Parkinson's disease? A case report.
000278 (2015)	Romain Lefaucheur [France] ; Floriane Le Goff [France] ; Gaëlle Gaillon [France] ; Aude Triquenot-Bagan [France] ; David Maltête [France]	Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
000283 (2015)	Emma D. Deeks [Oman]	Safinamide: first global approval.
000289 (2015)	Javier Castro-Hernández [Espagne] ; Domingo Afonso-Oramas [Espagne] ; Ignacio Cruz-Muros [Espagne] ; Josmar Salas-Hernández [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Rosario Moratalla [Espagne] ; Mark J. Millan [France] ; Tomás González-Hernández [Espagne]	Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
000295 (2015)	Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis]	Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
000301 (2015)	Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]	Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000312 (2015)	Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal]	New treatments for levodopa-induced motor complications.
000319 (2015)	Audrey Maillet [France] ; Stéphane Thobois ; Valérie Fraix ; Jérôme Redouté ; Didier Le Bars ; Franck Lavenne ; Philippe Derost ; Franck Durif ; Bastiaan R. Bloem ; Paul Krack ; Pierre Pollak ; Bettina Debû	Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.
000322 (2015)	H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis]	NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
000345 (2015)	Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni]	Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Antiparkinson Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Antiparkinson Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Antiparkinson Agents
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024